Nascent Biotech, Inc.
OTC:NBIO
0.2 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -2.088 | -2.801 | -0.47 | -0.959 | -4.004 | -1.369 | -2.221 | 1.137 | -4.149 | -2.152 | -1.918 | -0.689 |
| Depreciation & Amortization
| 0 | 1.343 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.001 |
| Deferred Income Tax
| 0 | 0.246 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.882 | 0.756 | 0.116 | 0.786 | 1.104 | 0.208 | 0.149 | 0.118 | 3.941 | 0.119 | 0 | 0 |
| Change In Working Capital
| 0.164 | -0.317 | 0.911 | -0.103 | 1.816 | 0.41 | 0.808 | -2.117 | 1.614 | 0.32 | 0.335 | 0.331 |
| Accounts Receivables
| 0 | 0 | 0.75 | -0.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.261 | -0.246 | 0.167 | 0.23 | 0.327 | 0.322 | 0.052 | 0 | -0.005 | -0.001 | 0.26 | 0 |
| Other Working Capital
| -0.097 | 0.246 | -0.006 | 0.417 | 1.489 | 0.088 | 0.808 | -2.117 | 1.614 | 0.32 | 0.335 | 0.331 |
| Other Non Cash Items
| -0.144 | -1.014 | -0.143 | -0.711 | 0.53 | 0.038 | 0.04 | 0.093 | 2.365 | 1.239 | 1.452 | 0.271 |
| Operating Cash Flow
| -1.186 | -1.787 | 0.413 | -0.987 | -0.554 | -0.712 | -1.224 | -0.769 | -0.17 | -0.473 | -0.13 | -0.086 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.828 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.828 | 0.08 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.828 | 0.08 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -0.175 | 1.657 | -0.321 | 0 | 0.2 | 0 | 0 | 0 | -0.06 | 0 | 0 | 0 |
| Common Stock Issued
| 1.561 | 0.208 | 0 | 0.64 | 0.115 | 0.643 | 1.166 | 0.325 | 0.696 | 1.295 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.696 | 1.295 | 0.05 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.208 | 0 | 1.625 | 0.336 | 0.083 | 0.046 | 0 | 0.696 | 1.295 | 0.163 | 0.086 |
| Financing Cash Flow
| 1.386 | 1.865 | -0.321 | 0.985 | 0.426 | 0.726 | 1.212 | 0.325 | 0.636 | 1.295 | 0.163 | 0.086 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0.2 | 0.078 | 0.093 | -0.002 | -0.128 | 0.014 | -0.013 | -0.444 | 0.466 | -0.006 | 0.113 | 0 |
| Cash At End Of Period
| 0.372 | 0.172 | 0.094 | 0.001 | 0.003 | 0.131 | 0.117 | 0.13 | 0.573 | 0.108 | 0.114 | 0 |